-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Silence Therapeutics plc quarterly/annual Income Tax Expense (Benefit) history and change rate from 2022 to Q3 2025.
- Silence Therapeutics plc Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $1K, a 98% decline year-over-year.
- Silence Therapeutics plc Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $335K.
- Silence Therapeutics plc annual Income Tax Expense (Benefit) for 2024 was $845K, a 11.6% decline from 2023.
- Silence Therapeutics plc annual Income Tax Expense (Benefit) for 2023 was $956K, a 39% increase from 2022.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)